A Study Evaluating the Effect of Botulinum Toxin Type A on Semen Quality in Patients With Benign Prostatic Hyperplasia

Clinical trial NCT00894517 · COMPLETED

Trial details

NCT number: NCT00894517
Sponsor: Allergan
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Benign Prostatic Hyperplasia

Start date: 2009-08-01
Primary completion: 2012-06-01
Enrollment: 61

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.